dorsaVi Ltd
dorsaVi Ltd (DVL.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for dorsaVi Ltd (DVL.AX), covering cash flow, earnings, and balance sheets.
dorsaVi Ltd (DVL.AX) Income Statement & Financial Overview
View the income breakdown for dorsaVi Ltd DVL.AX across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $653983.00 | $694109.00 | $610129.00 | $859606.00 |
| Cost of Revenue | $59321.00 | $711864.00 | $912236.00 | $1.26M |
| Gross Profit | $594662.00 | -$17755.00 | -$302107.00 | -$396746.00 |
| Gross Profit Ratio | $0.91 | -$0.03 | -$0.50 | -$0.46 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $1.15M |
| SG&A Expenses | $1.19M | $785789.00 | $606910.00 | $714206.00 |
| Operating Expenses | $1.19M | $765789.00 | $606910.00 | $714206.00 |
| Total Costs & Expenses | $1.25M | $1.48M | $1.52M | $1.97M |
| Interest Income | $0.00 | $5879.00 | $4924.00 | $6472.00 |
| Interest Expense | $0.00 | $3318.00 | $19026.00 | $16170.00 |
| Depreciation & Amortization | $32098.00 | $43332.00 | $35620.00 | $115713.00 |
| EBITDA | -$718977.00 | -$734333.00 | -$868473.00 | -$952167.00 |
| EBITDA Ratio | -$1.10 | -$1.06 | -$1.42 | -$1.16 |
| Operating Income | -$592414.00 | -$783544.00 | -$909020.00 | -$1.11M |
| Operating Income Ratio | -$0.91 | -$1.13 | -$1.49 | -$1.29 |
| Other Income/Expenses (Net) | -$156241.00 | $2561.00 | -$14099.00 | -$9698.00 |
| Income Before Tax | -$748655.00 | -$780983.00 | -$923119.00 | -$1.08M |
| Income Before Tax Ratio | -$1.14 | -$1.13 | -$1.51 | -$1.26 |
| Income Tax Expense | -$170113.00 | -$219485.00 | -$237035.00 | -$221277.00 |
| Net Income | -$578542.00 | -$561498.00 | -$686084.00 | -$862773.00 |
| Net Income Ratio | -$0.88 | -$0.81 | -$1.12 | -$1.004 |
| EPS | -$0.001 | -$0.001 | -$0.001 | -$0.002 |
| Diluted EPS | -$0.001 | -$0.001 | -$0.001 | -$0.002 |
| Weighted Avg Shares Outstanding | $642.82M | $615.18M | $567.99M | $538.46M |
| Weighted Avg Shares Outstanding (Diluted) | $672.38M | $615.18M | $567.99M | $538.46M |
Over the last four quarters, dorsaVi Ltd's revenue moved from $859606.00 in Q4 2023 to $653983.00 in Q2 2025. Operating income in Q2 2025 was -$592414.00, with a strong operating margin of -91%. Despite fluctuations in R&D and SG&A expenses, EBITDA for dorsaVi Ltd remained robust at -$718977.00, reflecting operational efficiency. Net income dropped to -$578542.00, with an EPS of -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan